Akari Therapeutics

Akari Therapeutics AKTX Stock

$7.18   7.004468%
Add to favorites
Market Cap
$16.70M
LOW - HIGH [24H]
$6.20 - $7.44
VOLUME [24H]
$15.27K
P/E Ratio
0
Earnings per share
$0.00
ISIN
US00972G2075
Price   Prediction

Akari Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Akari Therapeutics (AKTX) stock price today is 7.18 USD on Tech Market Small (+7% on the day). Updated .

Akari Therapeutics AKTX Financial and Trading Overview

Akari Therapeutics stock price 7.18 USD
Previous Close 6.71 USD
Open 7 USD
Bid 6.63 USD x 1700
Ask 7 USD x 200
Day's Range 6.2 - 7.44 USD
52 Week Range 3.02 - 29.32 USD
Volume 15.27K USD
Avg. Volume 58.54K USD
Market Cap 16.7M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 25.5 USD

AKTX Valuation Measures

Enterprise Value 10.96M USD
Trailing P/E N/A
Forward P/E -0.8300578
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.9374592
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Akari Therapeutics Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -59.38%
S&P500 52-Week Change 3.06%
52 Week High 29.32 USD
52 Week Low 3.02 USD
50-Day Moving Average 8.48 USD
200-Day Moving Average 8.84 USD

AKTX Share Statistics

Avg. Volume (3 month) 58.54K USD
Avg. Daily Volume (10-Days) 20.29K USD
Shares Outstanding 2.33M
Float 1.7M
Short Ratio 0.41
% Held by Insiders 16.03%
% Held by Institutions 9.62%
Shares Short 17.9K
Short % of Float 1.40%
Short % of Shares Outstanding 0.77%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:40

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -24.61%
Return on Equity (ttm) -146.32%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -29403000 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 5.74M USD
Total Cash Per Share (mrq) 2.47 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.484
Book Value Per Share (mrq) 7.659

Cash Flow Statement

Operating Cash Flow (ttm) -12863000 USD
Levered Free Cash Flow (ttm) -8328500 USD

Profile of Akari Therapeutics

Country United States
State FL
City Tampa
Address 401 East Jackson Street
ZIP 33602
Phone 929 274 7510
Website https://www.akaritx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 5

Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.

Q&A For Akari Therapeutics Stock

What is a current AKTX stock price?

Akari Therapeutics AKTX stock price today per share is 7.18 USD.

How to purchase Akari Therapeutics stock?

You can buy AKTX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Akari Therapeutics?

The stock symbol or ticker of Akari Therapeutics is AKTX.

Which industry does the Akari Therapeutics company belong to?

The Akari Therapeutics industry is Biotechnology.

How many shares does Akari Therapeutics have in circulation?

The max supply of Akari Therapeutics shares is 2.33M.

What is Akari Therapeutics Price to Earnings Ratio (PE Ratio)?

Akari Therapeutics PE Ratio is now.

What was Akari Therapeutics earnings per share over the trailing 12 months (TTM)?

Akari Therapeutics EPS is 0 USD over the trailing 12 months.

Which sector does the Akari Therapeutics company belong to?

The Akari Therapeutics sector is Healthcare.

Akari Therapeutics AKTX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Capital Market Composite RCMP US 100.96 USD —
-4.6
— — 100.89 USD — 105.64 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us US Tech Composite Total Return XCMP US 27958.09 USD —
-5.28
— — 27828.65 USD — 29466.09 USD — — — —
$2.07T
Total marketcap
$72.19B
Total volume
BTC 58.79%   •   ETH 10.04%
Dominance
Select currency